economy
중도 성향
An experimental lung-cancer drug could replace Keytruda one day. But investors aren’t wowed.
MarketWatch
조회 0
The highly anticipated study found that ivonescimab reduced the risk of death by 34% compared with another drug ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.